Presentation Information
[S14-5]Proposal of a novel therapeutic candidate for tuberous sclerosis based on the inhibitory effect of Rheb activation
○Tadayuki Shimada1, Hiroko Sugiura1, Kanato Yamagata1,2 (1.Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan, 2.Takada Nishishiro Hospital, Niigata, Japan)